Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality, and
prognosis assessment is crucial for guiding treatment decisions. In this study, we aimed to …

RNA editing is a widespread post-transcriptional mechanism to introduce single nucleotide
changes to RNA in human cancers. Here, we characterized the global RNA editing profiles …

Abstract A-to-I RNA editing is a long-known driving factor to the progression of
hepatocellular carcinoma (HCC); however, its importance is often neglected in HCC …

Aberrant RNA editing has emerged as a pivotal factor in the pathogenesis of hepatocellular
carcinoma (HCC), but the impact of RNA co-editing within HCC remains underexplored. We …

Purpose Hepatocellular carcinoma (HCC) is the sixth most lethal neoplasm worldwide.
Traditional biomarkers often exploit the relationship between a certain gene and cancer …

The epigenome encompasses a compendium of heritable but potentially reversible
modifications that collectively regulate gene expression and drive development and cellular …

Background: Hepatocellular carcinoma (HCC) is a malignant tumour with a poor prognosis.
The effect of DNA repair on prognosis cannot be ignored, and long non-coding RNA …

Hepatocellular carcinoma (HCC) is a primary malignancy with increasing incidence and
poor prognosis. Heterogeneity originating from genomic instability is one of the critical …

Background Liver cancer (LC) is one of the most fatal cancers throughout the world. More
efficient and sensitive gene signatures that could accurately predict survival in LC patients …

Background DNA damage repair (DDR) may affect tumorigenesis and therapeutic response
in hepatocellular carcinoma (HCC). Long noncoding RNAs (LncRNAs) can regulate DDR …